Only in Titles

           Search results for: Andarine C19H18F3N3O6HTΈ NL M L{    

paperclip

#31734960   // Save this To Up

A novel approach to the quantification of urinary aryl-propionamide-derived SARMs by UHPLC-MS/MS.

A simple and sensitive procedure for the quantification of two commonly abused aryl-propionamide-derived selective androgen receptor modulators (SARMs), namely S-4 (GTx-007, andarine) and S-22 (GTx-024, MK-2866, ostarine, enobosarm), has been described. Urine samples were prepared for analysis by means of a dispersive liquid-liquid microextraction using methanol and chloroform as dispersive and extracting solvents, respectively. Factors that might influence the extraction process as well as their optimum conditions were evaluated by Box-Benken and central composite designs. After extraction, the analytes were quantified by UHPLC-MS/MS. The proposed procedure was validated on human urine samples. As a result, for both SARMs the detection limits were observed at 0.05 ng/mL and calibration curves were linear in the concentration range of 0.25-50 ng/mL with the coefficient of determination of 0.998.

2180 related Products with: A novel approach to the quantification of urinary aryl-propionamide-derived SARMs by UHPLC-MS/MS.

FDA Standard Frozen Tissu FDA Standard Frozen Tissu MarkerGene™ Total Prote FDA Standard Frozen Tissu FDA Standard Frozen Tissu Cholera toxin antibody, M Analysis Tool for Custom  Methylamp Global DNA Me 1,6-Anhydro-2-O-p-toluene Diphtheria toxin antibody Analysis Tool for AAH-CYT Goat Anti-Clostridium tet

Related Pathways

paperclip

#31319382   // Save this To Up

Selective androgen receptor modulators (SARMs) have specific impacts on the mouse uterus.

Selective androgen receptor modulators (SARMs) have been proposed as therapeutics for women suffering from breast cancer, muscle wasting or urinary incontinence. The androgen receptor (AR) is expressed in the uterus but the impact of SARMs on the function of this organ is unknown. We used a mouse model to compare the impact of SARMs (GTx-007/Andarine®, GTx-024/Enobosarm®), Danazol (a synthetic androstane steroid) and dihydrotestosterone (DHT) on tissue architecture, cell proliferation and gene expression. Ovariectomised mice were treated daily for 7 days with compound or vehicle control (VC). Uterine morphometric characteristics were quantified using high-throughput image analysis (StrataQuest; TissueGnostics), protein and gene expression were evaluated by immunohistochemistry and RT-qPCR, respectively. Treatment with GTx-024, Danazol or DHT induced significant increases in body weight, uterine weight and the surface area of the endometrial stromal and epithelial compartments compared to VC. Treatment with GTx-007 had no impact on these parameters. GTx-024, Danazol and DHT all significantly increased the percentage of Ki67-positive cells in the stroma, but only GTx-024 had an impact on epithelial cell proliferation. GTx-007 significantly increased uterine expression of Wnt4 and Wnt7a, whereas GTx-024 and Danazol decreased their expression. In summary, the impact of GTx-024 and Danazol on uterine cells mirrored that of DHT, whereas GTx-007 had minimal impact on the tested parameters. This study has identified endpoints that have revealed differences in the effects of SARMs on uterine tissue and provides a template for preclinical studies comparing the impact of compounds targeting the AR on endometrial function.

2973 related Products with: Selective androgen receptor modulators (SARMs) have specific impacts on the mouse uterus.

Androgen Receptor , Mouse Androgen Receptor , Mouse Angiogenesis (Mouse) Anti Rat monoclonal anti mouse Goat Anti-Rat CCKA Recept Androgen Receptor Antibod Mouse anti human INF gamm Rabbit Anti-phospho-Eph r Cytokine (Mouse) Antibody Mouse Anti-Human TNF Rece Androgen Receptor (Phosph Mouse Monoclonal to Human

Related Pathways

paperclip

#31053351   // Save this To Up

Development and validation of a semi-quantitative ultra-high performance liquid chromatography-tandem mass spectrometry method for screening of selective androgen receptor modulators in urine.

A semi-quantitative method was developed to monitor the misuse of 15 SARM compounds belonging to nine different families, in urine matrices from a range of species (equine, canine, human, bovine and murine). SARM residues were extracted from urine (200 μL) with tert-butyl methyl ether (TBME) without further clean-up and analysed by ultra-high performance liquid chromatography coupled to tandem mass spectrometry (UHPLC-MS/MS). A 12 min gradient separation was carried out on a Luna Omega Polar C18 column, employing water and methanol, both containing 0.1% acetic acid (v/v), as mobile phases. The mass spectrometer was operated both in positive and negative electrospray ionisation modes (ESI±), with acquisition in selected reaction monitoring (SRM) mode. Validation was performed according to the EU Commission Decision 2002/657/EC criteria and European Union Reference Laboratories for Residues (EU-RLs) guidelines with CCβ values determined at 1 ng mL, excluding andarine (2 ng mL) and BMS-564929 (5 ng mL), in all species. This rapid, simple and cost effective assay was employed for screening of bovine, equine, canine and human urine to determine the potential level of SARMs abuse in stock farming, competition animals as well as amateur and elite athletes, ensuring consumer safety and fair play in animal and human performance sports.

2650 related Products with: Development and validation of a semi-quantitative ultra-high performance liquid chromatography-tandem mass spectrometry method for screening of selective androgen receptor modulators in urine.

EnzyChrom™ Kinase Assay T-Cell Receptor Signaling QuantiChrom™ Formaldehy Androgen Receptor (Ab-650 Androgen Receptor Ab-1 An Androgen Receptor Rabbit Anti-Human Androge Androgen Receptor Antibod Recombinant Human Androge Androgen Receptor (Phosph Androgen Receptor , Mouse Nuclear Membrane Receptor

Related Pathways

paperclip

#30617860   // Save this To Up

TiO Photocatalyzed Oxidation of Drugs Studied by Laser Ablation Electrospray Ionization Mass Spectrometry.

In drug discovery, it is important to identify phase I metabolic modifications as early as possible to screen for inactivation of drugs and/or activation of prodrugs. As the major class of reactions in phase I metabolism is oxidation reactions, oxidation of drugs with TiO photocatalysis can be used as a simple non-biological method to initially eliminate (pro)drug candidates with an undesired phase I oxidation metabolism. Analysis of reaction products is commonly achieved with mass spectrometry coupled to chromatography. However, sample throughput can be substantially increased by eliminating pretreatment steps and exploiting the potential of ambient ionization mass spectrometry (MS). Furthermore, online monitoring of reactions in a time-resolved way would identify sequential modification steps. Here, we introduce a novel (time-resolved) TiO-photocatalysis laser ablation electrospray ionization (LAESI) MS method for the analysis of drug candidates. This method was proven to be compatible with both TiO-coated glass slides as well as solutions containing suspended TiO nanoparticles, and the results were in excellent agreement with studies on biological oxidation of verapamil, buspirone, testosterone, andarine, and ostarine. Finally, a time-resolved LAESI MS setup was developed and initial results for verapamil showed excellent analytical stability for online photocatalyzed oxidation reactions within the set-up up to at least 1 h. Graphical Abstract.

2476 related Products with: TiO Photocatalyzed Oxidation of Drugs Studied by Laser Ablation Electrospray Ionization Mass Spectrometry.

Fontana-Masson Stain Kit Apopxin™ PS Sensor V510 Trichrome Stain Kit (Mod Ofloxacin CAS Number [824 Apopxin™ PS Sensor V460 Fontana-Masson Stain Kit Anti AGE 3 Monoclonal Ant Trichrome Stain Kit (Mod

Related Pathways

paperclip

#29319101   // Save this To Up

Structural elucidation of major selective androgen receptor modulator (SARM) metabolites for doping control.

Selective androgen receptor modulators (SARMs) are a class of androgen receptor drugs, which have a high potential to be performance enhancers in human and animal sports. Arylpropionamides are one of the major SARM classes and get rapidly metabolized significantly complicating simple detection of misconduct in blood or urine sample analysis. Specific drug-derived metabolites are required as references due to a short half-life of the parent compound but are generally lacking. The difficulty in metabolism studies is the determination of the correct regio and stereoselectivity during metabolic conversion processes. In this study, we have elucidated and verified the chemical structure of two major equine arylpropionamide-based SARM metabolites using a combination of chemical synthesis and liquid chromatography-mass spectrometry (LC-MS) analysis. These synthesized SARM-derived metabolites can readily be utilized as reference standards for routine mass spectrometry-based doping control analysis of at least three commonly used performance-enhancing drugs to unambigously identify misconduct.

1907 related Products with: Structural elucidation of major selective androgen receptor modulator (SARM) metabolites for doping control.

Androgen Receptor , Mouse Rabbit Anti-Human Androge Anti Androgen Receptor pr Rabbit anti Androgen Rece Rabbit Anti-Human Androge Androgen Receptor Antibod Androgen Receptor Estrogen receptor IHC con Androgen Receptor (Ab-650 Androgen Receptor (Ab 650 Androgen Receptor (Phosph Androgen Receptor (Phosph

Related Pathways

paperclip

#29183075   // Save this To Up

Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet.

Recent reports have described the increasing use of nonsteroidal selective androgen receptor modulators, which have not been approved by the US Food and Drug Administration (FDA), to enhance appearance and performance. The composition and purity of such products is not known.

1878 related Products with: Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet.

AZD-3514 Mechanisms: Andr Rabbit Anti-Human Androge Androgen Receptor (Ab-650 Androgen Receptor (Phosph Androgen Receptor Ab 1 Rabbit anti Androgen Rece Rabbit Anti-Human Androge Anti-Androgen Receptor pr Androgen Receptor Androgen Receptor Antibod Rabbit Anti-Human Androge Androgen Receptor (Phosph

Related Pathways

paperclip

#   // Save this To Up


1080 related Products with:



Related Pathways

  •  
  • No related Items
paperclip

#26969924   // Save this To Up

Investigation of the selective androgen receptor modulators S1, S4 and S22 and their metabolites in equine plasma using high-resolution mass spectrometry.

Selective androgen receptor modulators (SARMs) are prohibited in sports due to their performance enhancing ability. It is important to investigate the metabolism to determine appropriate targets for doping control. This is the first study where the equine metabolites of SARMs S1, S4 (Andarine) and S22 (Ostarine) have been studied in plasma.

2756 related Products with: Investigation of the selective androgen receptor modulators S1, S4 and S22 and their metabolites in equine plasma using high-resolution mass spectrometry.

Goat Anti-Human Androgen Anti-Androgen Receptor pr Androgen Receptor (Phosph AZD-3514 Mechanisms: Andr Androgen Receptor (Phosph Androgen Receptor , Mouse Androgen Receptor Rabbit anti Androgen Rece Androgen Receptor (Phosph Androgen Receptor Antibod Rabbit Anti-Human Androge Androgen Receptor Antibod

Related Pathways

paperclip

#26456227   // Save this To Up

Detection of the selective androgen receptor modulator andarine (S-4) in a routine equine blood doping control sample.


1263 related Products with: Detection of the selective androgen receptor modulator andarine (S-4) in a routine equine blood doping control sample.

Bladder cancer test tissu Androgen Receptor (Ab 650 Brain cancer test tissue Goat Anti-Human Androgen Mouse Interleukin Array Goat Anti- EP1 receptor P Prostate cancer test tiss Goat Anti-Human Leptin Re IGF-1R Signaling Phospho- Colon adenocarcinoma tiss Penis cancer test tissue Rabbit Anti-Insulin Recep

Related Pathways

  •  
  • No related Items
paperclip

#24633910   // Save this To Up

Therapies for musculoskeletal disease: can we treat two birds with one stone?

Musculoskeletal diseases are highly prevalent with staggering annual health care costs across the globe. The combined wasting of muscle (sarcopenia) and bone (osteoporosis)-both in normal aging and pathologic states-can lead to vastly compounded risk for fracture in patients. Until now, our therapeutic approach to the prevention of such fractures has focused solely on bone, but our increasing understanding of the interconnected biology of muscle and bone has begun to shift our treatment paradigm for musculoskeletal disease. Targeting pathways that centrally regulate both bone and muscle (eg, GH/IGF-1, sex steroids, etc.) and newly emerging pathways that might facilitate communication between these 2 tissues (eg, activin/myostatin) might allow a greater therapeutic benefit and/or previously unanticipated means by which to treat these frail patients and prevent fracture. In this review, we will discuss a number of therapies currently under development that aim to treat musculoskeletal disease in precisely such a holistic fashion.

1690 related Products with: Therapies for musculoskeletal disease: can we treat two birds with one stone?

Gallbladder disease spect Peripheral nerve disease Blood vessel disease spec Adrenal gland disease spe Thymus disease spectrum ( Colon disease spectrum (c Ovarian disease spectrum Fallopian tube disease sp Rectal disease spectrum ( Hepatic disease spectrum Multiple organ, diseased Canine CRP ELISA Kit

Related Pathways